You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2025 › December › 18
Medline
7 months ago
This week, Medline launched the biggest IPO of 2025. But, it wasn't the only large public listing this year, according to a CNBC Pro data analysis.
Medline stock is a little too expensive to buy post IPO, Jim Cramer says ○
CNBC's Jim Cramer reviewed Medline, a medical supplies giant that made its market debut Wednesday.
page 1 of 1